Status:
UNKNOWN
Reason Evaluation of Initial Treatment Failure in Patients With CAP
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Community-acquired Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
This research is to evaluate the effect of different antibiotics (Moxifloxacin Hydrochloride and Sodium Chloride Injection vs. β-lactam antibiotics for injection +/- Azithromycin for Injection) on the...
Eligibility Criteria
Inclusion
- Age\>=18y.
- Diagnosed with CAP.
- Need hospitalization.
- Receive Moxifloxacin Hydrochloride and Sodium Chloride Injection or β-lactam antibiotics for injection +/- Azithromycin for Injection as initial treatment.
- Signed informed consent form.
Exclusion
- Patients who meet any of the following criteria will not be included in the study:
- Pneumonia is aquired more than 48h after admission or the patient was admitted to hospital within 30 days prior to admission.
- Start antibiotic treatment before admission.
- Gestational period or suckling period.
- Admitted to ICU.
- Immunocompromised patients.
- Pneumonia is the terminal event of a serious disease.
- Tuberculosis, lung cancer, non-infectious interstitial lung disease, pulmonary edema, atelectasis, pulmonary embolism, pulmanory eosinophilia, pulmonary vasculitis.
- Allergic to the antibiotics of the study.
Key Trial Info
Start Date :
November 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2019
Estimated Enrollment :
314 Patients enrolled
Trial Details
Trial ID
NCT03280004
Start Date
November 20 2017
End Date
November 30 2019
Last Update
April 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jun Xu
Beijing, Beijing Municipality, China, 100730